Navigation Links
GlaxoSmithKline Opens $600million Vaccine Plant In Singapore
Date:6/16/2009

New state-of-the-art vaccine plant to hire 200 staff in Singapore, GSK and the Singapore Economic Development Board (EDB) set up endowment fund.

Singapore (PRWEB) June 16, 2009 -- Singapore's pharmaceutical industry has moved into higher gear, with the opening of a state-of-the-art vaccine plant. The new plant is GlaxoSmithKline's (GSK) first primary vaccine manufacturing facility and its biggest investment in Asia. The plant, which involves a total investment of S$600 million, underscores GSK's strong commitment to Singapore.

GSK will initially employ about 200 staff and the company is investing in training and development to equip them with the skills and knowledge to operate the new facility.

In addition, as part of an ongoing effort to develop talent and leadership in Singapore, GSK is setting up a $30 million endowment fund here to nurture minds in the fields of green manufacturing and public health policy. The Singapore Economic Development Board (EBD) will boost the fund by a further $20 million.

GSK has had a strong presence in Singapore for the last 50 years since 1959. Besides the local pharmaceutical and consumer healthcare operations, Singapore serves as the headquarters for GSK's Asia-Pacific operations and houses the Singapore Research Centre at Biopolis. In addition to this new vaccine plant, GSK has two global manufacturing and supply sites located in Singapore. With more than 1000 staff, GSK's total investment in the city-state now exceeds S$1.5 billion.

Asia is emerging as a global powerhouse in the biomedical sciences industry, with its fast-expanding market and massive talent base. As a leading bio-cluster in Asia, Singapore provides access to world-class scientific and clinical excellence, excellent connectivity to key regional markets as well as strategic partnership opportunities with research institutes, corporate labs and public hospitals.

Leveraging Singapore's strong scientific and economic fundamentals, global biomedical sciences companies invested more than $500 million here in the year 2008 alone. A growing base of more than 50 global pharmaceutical, biotechnology and medical technology companies are carrying out R&D in Singapore, alongside 30 public-sector research and medical institutes. Amongst them, more than 10 leading multi-national companies have established their regional headquarters in Singapore. They include AstraZeneca, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Genzyme, GlaxoSmithKline, Merck, Quintiles and Sanofi-Aventis. Their continued confidence is testament to Singapore's position as a leading global manufacturing site for innovative medicines.

To find out more about working and living in Singapore, log on to Contact Singapore's website at www.contactsingapore.sg or search for jobs at www.contactsingapore.sg/jobs.

For more information about Singapore's biomedical sciences sector, log on to the Singapore Economic Development Board's website at http://www.edb.gov.sg/edb/sg/en_uk/index/industry_sectors/pharmaceuticals__/industry_background.html and the Agency for Science, Technology and Research's website at http://www.a-star.edu.sg.

About Contact Singapore

Contact Singapore is an alliance of the Singapore Economic Development Board and Ministry of Manpower. It aims to attract global talent to work, invest and live in Singapore.

With offices in Asia Pacific, Europe and North America, Contact Singapore is the one-stop center for those who wish to pursue a rewarding career in Singapore, as well as business leaders and entrepreneurs who are keen to invest in or initiate new business activities here. Contact Singapore actively links Singapore-based employers with global talent and provides updates on career opportunities and industry developments in Singapore. We work with private sector partners to facilitate the interests of potential individual investors in Singapore.

For more information on working, investing and living in Singapore, please visit www.contactsingapore.sg.

###

Read the full story at http://www.prweb.com/releases/contact-singapore/pharmaceutical-hub/prweb2534644.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands
2. GlaxoSmithKline Travel Health: 55 percent of travellers needlessly put themselves at risk from a potentially fatal virus
3. Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009
4. GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million
5. GlaxoSmithKline Update: Influenza A (H1N1)
6. GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company
7. GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder
8. IADR and GlaxoSmithKline Consumer Healthcare announce winners of 2009 Innovation in Oral Care Awards
9. GlaxoSmithKline Consumer Healthcare to Reach 85 Percent of the Worlds Smokers with Quit Aids
10. GlaxoSmithKline Consumer Healthcare Helps to Bridge Oral Care Gap in Appalachia
11. Activplant Corporation Announces Global Agreement with GlaxoSmithKline
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
GlaxoSmithKline Opens $600million Vaccine Plant In Singapore
(Date:5/26/2016)... NJ (PRWEB) , ... May 26, 2016 , ... ... recognized as an NJ Top Doc! Along with his wonderful accolades and stellar ... in podiatry. Congratulations, Dr. Batelli! , Dr. Eugene Batelli is a highly ...
(Date:5/26/2016)... ... May 26, 2016 , ... Power Systems, ... the first PowerWave Instructor Certification Course in Stoughton, Massachusetts. The course was led ... professional through the 8 hour interactive course to qualify participants as certified PowerWave ...
(Date:5/26/2016)... ... May 26, 2016 , ... Bunion Bootie , the manufacturer ... treatment was more than humbled by customer demand over the Mother’s Day Weekend promotion. ... sale. Now that Bunion Bootie has completely replenished its inventory levels, it hopes to ...
(Date:5/26/2016)... ... May 26, 2016 , ... OncLive® , a ... Cancer Institute-designated University of Virginia (UVA) Cancer Center to its quickly ... and marketing teams will publicize and promote public awareness of UVA Cancer Center’s ...
(Date:5/26/2016)... ... May 26, 2016 , ... On May 23rd during the National Eye ... and international water advocate, was honored by Ashram, Inc. as the world’s foremost water ... knelt on the banks of the Nile to fill their red clay pots with ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 Since ... matured into an essential life science tool for conducting ... applications. BCC Research reveals in its new report that ... growth phase, one powered by a range of new ...      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
(Date:5/25/2016)... 25, 2016 According to a ... (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), ... (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to 2021", ... Animation Market for the forecast period of 2016 to ... Million by 2021 from USD 117.3 Million in 2016, ...
Breaking Medicine Technology: